VC firm

Pontifax Venture Capital

Kingmaker Tier

Kingmaker Tier: 96 out of 100

Also known as Pontifax

Biotech & therapeutics
Care delivery & digital health
Health IT
Medical devices & diagnostics
Mental health & wellness
Women's & family health
Multi stage
Global
VC
B2B

Investor type: VC
Investing status: Activeas of 2026-09-17Source (opens in a new tab)
Headquarters: Herzeliya, Israel
Founded: 2004
Assets under management: $1.2BStated by firm, as of 2026-09-17Source (opens in a new tab)
Latest fund size: $127MSEC amount sold, as of 2019-10-04Source (opens in a new tab)
Funds: 4

Open relationship map

Claim, correct or request removal

Record updated 27 September 2026

About

Founded in 2004, Pontifax is a healthcare-dedicated venture capital firm with $1.2 billion under management.

Investment approach

Thesis: Pontifax invests in breakthrough innovation regardless of therapeutic area or development stage.Source (opens in a new tab)
Investing status notes: We seek transformative, cutting-edge life sciences technologies at all development stages.

Funds

Pontifax Global Food & Agriculture Technology Fund II L.P.: $127MVintage 2019, Main fund, SEC amount sold
Pontifax Global Food & Agriculture Technology Fund II-A L.P.: $12.8MVintage 2019, Main fund, SEC amount sold
Pontifax Global Food & Agriculture Technology Fund L.P.: $51.7MVintage 2016, SEC amount sold
Pontifax Global Food & Agriculture Technology (Feeder) Fund L.P.: $7.2MVintage 2016, Feeder, SEC amount sold

Locations

Headquarters: Herzeliya, Israel